Presatovir
Clinical data | |
---|---|
Trade names | Presatovir |
Legal status | |
Legal status | |
Identifiers | |
| |
JSmol) | |
| |
|
Presatovir (GS-5806) is an antiviral drug which was developed as a treatment for respiratory syncytial virus.[1][2] It acts as a fusion inhibitor, and has shown promising results in Phase II clinical trials.[3][4]